Authors: Samuele Cortese; Cinzia Del Giovane; Samuel Chamberlain; Alexandra Philipsen; Susan Young; Andrea Bilbow; Andrea Cipriani · Research

How Do Different Treatments for Adult ADHD Compare?

A systematic review and network meta-analysis will compare medications, non-drug therapies, and their combinations for treating adult ADHD.

Source: Cortese, S., Del Giovane, C., Chamberlain, S., Philipsen, A., Young, S., Bilbow, A., & Cipriani, A. (2022). Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis. BMJ Open, 12(3), e058102. https://doi.org/10.1136/bmjopen-2021-058102

What you need to know

  • This study will compare the effectiveness of different treatments for adult ADHD, including medications, non-drug therapies, and combinations.
  • It will be the first network meta-analysis to include both drug and non-drug treatments for adult ADHD in the same analysis.
  • The results will help patients, families, and clinicians make more informed decisions about ADHD treatment options.

Understanding treatment options for adult ADHD

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that often persists into adulthood. About 2.5% of adults have ADHD, which can significantly impact many areas of life if left untreated. Adults with ADHD may struggle with focus, organization, impulsivity, and emotional regulation. This can lead to problems at work, in relationships, and with overall quality of life.

There are several treatment options available for adult ADHD, including medications and non-drug therapies. However, it’s not always clear how these different treatments compare to each other in terms of benefits and side effects. This makes it challenging for patients and doctors to decide on the best treatment approach.

Current guidelines from the UK’s National Institute for Health and Care Excellence (NICE) recommend medication as the first treatment option for most adults with ADHD. Specifically, they suggest trying stimulant medications like methylphenidate or amphetamines first. Non-stimulant medications like atomoxetine are recommended as a second option. Psychological therapies are suggested as an addition to medication or as an alternative for those who can’t or don’t want to take medication.

However, these recommendations were based on limited evidence available when the guidelines were created. Since then, many new studies have been published on various treatments for adult ADHD. There’s a need to update our understanding of how different treatments compare, especially given the growing interest in non-drug approaches.

A comprehensive comparison of ADHD treatments

To address this knowledge gap, researchers have designed a study to comprehensively compare different treatments for adult ADHD. This study will use a special type of analysis called a network meta-analysis. Unlike a traditional meta-analysis that only compares two treatments at a time, a network meta-analysis can compare multiple treatments simultaneously, even if they haven’t been directly compared in previous studies.

The researchers will search for all relevant clinical trials on treatments for adult ADHD. This will include studies on:

  • Medications (both stimulants and non-stimulants)
  • Psychological therapies (like cognitive behavioral therapy)
  • Cognitive training
  • Neurofeedback
  • Mindfulness-based interventions
  • Combinations of medication and non-drug therapies

They will look at how these treatments affect several important outcomes:

  1. ADHD symptoms (inattention, hyperactivity, impulsivity)
  2. How well people tolerate the treatment (measured by how many people drop out)
  3. Side effects
  4. Emotional regulation
  5. Executive functioning (skills like planning, organizing, and time management)
  6. Quality of life

By analyzing all this information together, the researchers hope to answer several key questions:

  • Which treatments are most effective for reducing ADHD symptoms in adults?
  • How do medications and non-drug therapies compare in terms of effectiveness?
  • Are some treatments better tolerated or have fewer side effects than others?
  • Do certain treatments work better for specific ADHD-related problems (like emotional regulation or executive functioning)?
  • Are combination treatments more effective than single treatments?

How the study will work

The researchers will follow a careful process to ensure their results are as reliable as possible:

  1. Comprehensive search: They will search multiple databases to find all relevant studies, including unpublished data from drug companies and researchers.

  2. Quality assessment: Each study will be evaluated for potential biases or limitations that could affect its results.

  3. Data extraction: Key information from each study will be carefully collected and organized.

  4. Network meta-analysis: Advanced statistical methods will be used to compare all the treatments and rank them based on effectiveness and tolerability.

  5. Subgroup analyses: The researchers will look at whether certain factors (like ADHD severity or presence of other mental health conditions) affect how well treatments work.

  6. Assessing confidence in the results: They will use established methods to determine how certain we can be about the findings.

Potential impact and limitations

This study has the potential to significantly impact ADHD treatment recommendations and clinical practice. By providing a comprehensive comparison of different treatments, it could help:

  • Patients and families make more informed decisions about treatment options
  • Doctors tailor treatment recommendations to individual patient needs and preferences
  • Policymakers update clinical guidelines based on the most current evidence
  • Researchers identify gaps in current knowledge and priorities for future studies

However, it’s important to note some limitations of this approach:

  • The quality of the results depends on the quality of the original studies included in the analysis.
  • There may be differences between studies in how they measure outcomes or define ADHD, which could affect the comparisons.
  • The analysis will only include group-level data, not individual patient data, which limits the ability to identify factors that might predict who will respond best to specific treatments.

Conclusions

  • This study will provide the most comprehensive comparison to date of different treatments for adult ADHD.
  • The results could help improve treatment decision-making and clinical guidelines.
  • While there are some limitations, this research has the potential to significantly advance our understanding of how to best treat adult ADHD.

As an adult with ADHD or a family member of someone with ADHD, you may want to keep an eye out for the results of this study. It could provide valuable information to discuss with your doctor when considering treatment options. Remember that ADHD treatment often requires a personalized approach, and what works best can vary from person to person.

Back to Blog

Related Articles

View All Articles »